Khapzory patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11541012 ACROTECH BIOPHARMA Compositions comprising disodium levofolinate
Mar, 2039

(15 years from now)

Khapzory is owned by Acrotech Biopharma.

Khapzory contains Levoleucovorin.

Khapzory has a total of 1 drug patent out of which 0 drug patents have expired.

Khapzory was authorised for market use on 19 October, 2018.

Khapzory is available in powder;intravenous dosage forms.

The generics of Khapzory are possible to be released after 25 March, 2039.

Drugs and Companies using LEVOLEUCOVORIN ingredient

Market Authorisation Date: 19 October, 2018

Treatment: NA


More Information on Dosage

KHAPZORY family patents

Family Patents